Peer-influenced content. Sources you trust. No registration required. This is HCN.

Articles related to IMMUNOTHERAPY

MashupMD

Pembrolizumab vs. Chemotherapy for Microsatellite Instability-High or Mismatch Repair-Deficient Metastatic CRC

Medical Oncology May 4th 2022

Journal of Clinical Oncology

Landscape of KRAS(G12C), Associated Genomic Alterations, and Interrelation w. Immuno-Oncology Biomarkers in KRAS-Mutated Cancers

Medical Oncology May 4th 2022

Clinical Advances in Hematology & Oncology

Managing Adverse Events of Immunotherapy in Breast Cancer

Medical Oncology May 4th 2022

Cancer Therapy Advisor

Adebrelimab Improves PFS, OS in Extensive-Stage Small Cell Lung Cancer

Medical Oncology April 26th 2022

Clinical Oncology News

Adding Palbociclib to Endocrine Therapy Shows No Benefit in Study

Medical Oncology April 12th 2022

Journal of Clinical Oncology

Pembrolizumab Alone or with Chemotherapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

Medical Oncology April 12th 2022

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form